Birth defects linked to potent anti-epilepsy pills have led to strict new prescription rules being introduced. Patients below the age of 55 will no longer be able to start on sodium valproate unless two doctors sign-off on the treatment. The medication has been condemned as the 'new thalidomide' due to its risk of causing serious deformities and learning difficulties when taken by pregnant women - a reference to the 1960s morning sickness treatment which caused life-threatening birth defects. ...read